304 results on '"Wei, Mingtian"'
Search Results
2. Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts
3. Methylene blue can increase the number of lymph nodes harvested in colorectal cancer: a meta-analysis
4. The effect of BMI on long-term outcome in patients with rectal cancer and establishment of a nomogram prediction model
5. Technique to match mesorectal lymph nodes imaging findings to histopathology: node-by-node comparison
6. Trim28 citrullination maintains mouse embryonic stem cell pluripotency via regulating Nanog and Klf4 transcription
7. Neoadjuvant chemotherapy (CAPOX) alone for low- and intermediate-risk stage II/III rectal cancer: Long-term follow-up of a prospective single-arm study
8. Day-case loop ileostomy reversal based on the community hospital joined enhanced recovery after surgery (CHJ-ERAS) program in China: Safe and feasible
9. Comparison of compressed sensing-sensitivity encoding (CS-SENSE) accelerated 3D T2W TSE sequence versus conventional 3D and 2D T2W TSE sequences in rectal cancer: a prospective study
10. Establishment and validation of nomograms for predicting mesorectal lymph node staging and restaging
11. eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation
12. Circulating tumor DNA as a predictor of treatment response to neoadjuvant chemotherapy in stage 2/3 rectal cancer without high risks: Subset analysis from the COPEC trial.
13. TeachMe: a web-based teaching system for annotating abdominal lymph nodes
14. Frailty index is useful for predicting postoperative morbidity in older patients undergoing gastrointestinal surgery: a prospective cohort study
15. Distinctive features of small vessels on the mesorectal and parietal pelvic fascia as important landmarks in guiding precise inter-fascial dissection for low rectal cancer
16. Single-incision versus conventional multiport laparoscopic surgery for colorectal cancer: a meta-analysis of randomized controlled trials and propensity-score matched studies
17. Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging
18. Diagnosis and treatment of obturator hernia: retrospective analysis of 86 clinical cases at a single institution
19. Oxaliplatin versus mitomycin C in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies
20. Ligating the rectum with cable tie facilitates rectum transection in laparoscopic anterior resection of rectal cancer
21. Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer
22. Comparison of laparoscopic lateral lymph node dissection for rectal cancer with and without routine resection of the visceral branches of internal iliac artery
23. Can neoadjuvant chemoradiotherapy combined with immunotherapy benefit patients with microsatellite stable locally advanced rectal cancer? a pooled and integration analysis
24. An attention-based neural network model for automatic partition of abdominal lymph nodes in CT imaging
25. A Modified Technique of Laparoscopic Lateral Lymph Node Dissection Combining Fascia-Oriented Dissection and Routine Upfront Distal Visceral Vessels Ligation for Mid to Low-Lying Rectal Cancer
26. Closure of pelvic peritoneum with bladder peritoneum flap reconstruction after laparoscopic extralevator abdominoperineal excision: A prospective stage II study
27. Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial
28. miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1
29. The effect of pericolic lymph nodes metastasis beyond 10 cm proximal to the tumor on patients with rectal cancer
30. Comparison of laparoscopic lateral lymph node dissection for rectal cancer with and without routine resection of the visceral branches of internal iliac artery.
31. Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis
32. Feasibility of a unidirectionally progressive, pancreas-oriented procedure for laparoscopic D3 right hemicolectomy
33. The same parastomal hernia repairs rate in the different approaches to colostomy
34. Letter to the editor regarding “Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?”
35. A Novel Laparoscopic Technique With a Bladder Peritoneum Flap Closure for Pelvic Cavity for Patients With Rigid Pelvic Peritoneum After Neoadjuvant Radiotherapy in Laparoscopic Extralevator Abdominoperineal Excision
36. Preservation versus non-preservation of left colic artery in colorectal cancer surgery: An updated systematic review and meta-analysis
37. First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis
38. Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
39. Which site is better for prophylactic ileostomy after laparoscopic rectal cancer surgery? By the specimen extraction site or new site: A systematic review and meta-analysis
40. DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis
41. Closure of Pelvic Peritoneum with Bladder Peritoneum Flap Reconstruction after Laparoscopic Extralevator Abdominoperineal Excision: A Stage II Study According to the IDEAL Framework
42. Additional file 2 of Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial)
43. Additional file 4 of Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial)
44. Additional file 3 of Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial)
45. Additional file 4 of Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts
46. Additional file 3 of Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts
47. Additional file 5 of Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial)
48. Additional file 1 of Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial)
49. Additional file 2 of Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts
50. Comprehensive Analysis of Potential Prognostic Values of ANGPTLs in Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.